Back to search results

Understanding and Improving Cardiometabolic Health for People with HIV

This observational study aims to understand and improve how people living with HIV (PLWH) manage common health conditions like high blood pressure (hypertension), unhealthy cholesterol levels (dyslipidemia), and type 2 diabetes. The study has three main goals: first, to identify everyday factors that help or hinder PLWH from reaching their treatment goals for these conditions; second, to assess how well PLWH understand and feel confident in managing their own health; and third, to use this information to create better support and education programs. You might be eligible if you are at least 35 years old, live with HIV, and have one or more of these cardiometabolic conditions. The study is currently unclear about its recruitment status.

Study design
This is an observational study planning to enroll 150 participants. It aims to gather information through interviews and surveys.
What's involved
Participants in Aim 1 will take photographs and participate in in-depth interviews. Participants in Aim 2 will complete a survey.
Compensation
Not stated in the trial record.
Follow-up
Some aspects of the study are measured at 2 weeks after enrollment, at baseline, and up to 3 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05129345

Addressing Barriers to Achieving Cardiometabolic Disorders Prevention and Treatment Goals for PLWH in the SE US

Recruiting
Not specifiedAges 18+Observational
Duke University
~150 participants
Updated 2025-07-24 on ClinicalTrials.gov

At a glance

Recruiting sites
2 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Aim 1: Number of social determinants of cardiometabolic health identified from interviews
Measured over 2 weeks after enrollment
+2 more outcomes measured

Conditions

Hypertension
Dyslipidemias
Type 2 Diabetes
HIV-1-infection

Explore related trials

DyslipidemiaHIV InfectionHypertensionType 2 Diabetes Mellitus

Where it's being run

2 sites across 1 states
North Carolina2

Study leadership

  • Charles Muiruri, PhD · PRINCIPAL_INVESTIGATOR · Duke University

Who to contact

Stuart T Carr, BA
[email protected]
919 668-4849
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

People living with HIV who are at least 35 years of age and who have one or more of the following conditions: hypertension, dyslipidemia, or type 2 diabetes.
Participants recruited from the participating clinics and community based organizations and may include, HIV providers, nurses, pharmacists, people living with HIV who have cardiometabolic disorders, and representatives of the community advisory boards, and any other key stakeholders. Age 18 or older.

Exclusion

Those who don't understand English and those who are blind.

What this trial measures

  • Aim 1: Number of social determinants of cardiometabolic health identified from interviews2 weeks after enrollment

    Interviews with PLWH who have cardiometabolic disorders to determine salient barriers and facilitators of achieving treatment goals for cardiometabolic disorders

  • Aim 2: Patient engagement in healthcare as measured by the Patient Activation Measure (PAM)Baseline

    Assess PLWH knowledge, skills, and confidence for self-management using the PAM which is a 13 item survey, Likert scale from strongly disagree to agree strongly.

  • Aim 3: Number of strategies modified in the self-management support and educationUp to 3 months

    Tailoring of self-management support and education intervention using stakeholder engagement strategies